Celldex Therapeutics (CLDX) Stock Highlights

25.14 | -0.95%

2024-12-21 03:45:21

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Statistics

Range Today

24.83 25.95

Volume Today 2.17M

Range 1 Year

22.93 53.18

Volume 1 Year 220.77M

Range 3 Year

19.85 53.18

Volume 3 Year 518.92M

Range 10 Year

1.5 492.3

Volume 10 Year 1.17B

Highlights

Market Capitalization 1.74B (small)

Floating Shares 66.16M

Current Price 25.14

Price To Earnings -10.28

Price To Revenue 100.55

Price To Book 2.21

Earnings Per Share -2.58

Payout Ratio 0%

Performance

Latest -0.95%

1 Month +0.56%

3 Months -38.88%

6 Months -27.05%

1 Year -34.74%

3 Years -33.7%

5 Years +1012.39%

10 Years -91.01%

Benchmarks

Market Capitalization

60 / 368

Gross Profits

224 / 278

Total Revenue

205 / 300

Total Rank

301 / 368

Free Cashflow

213 / 352

Performance 5 years

6 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.